RHK

DE0007042301

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:36:08 2024-04-25 am EDT			5-day change	1st Jan Change
12.8 ^EUR	-0.78%		+17.43%	+28.00%

Apr. 17	Lauterbach wants to press ahead with hospital reform despite differences	DP
Apr. 17	State report warns of risks in hospital reform	DP

RHÖN-KLINIKUM AG : Receives a Sell rating from Credit Suisse

August 05, 2019 at 05:11 am EDT

Credit Suisse reiterate its Sell rating. The target price remains unchanged at EUR 16.50.

Latest news about RHÖN-KLINIKUM AG

Lauterbach wants to press ahead with hospital reform despite differences	Apr. 17	DP
State report warns of risks in hospital reform	Apr. 17	DP
Warnings against cutbacks in hospital reform	Apr. 17	DP
Federal and state governments to discuss hospital reform again	Apr. 17	DP
Hospitals facing restructuring - Lauterbach expects 'strong momentum' from fall	Apr. 11	DP
Lauterbach predicts 'strong dynamics' for clinics in the fall	Apr. 11	DP
Top-level talks on hospital reform planned for Thursday	Apr. 08	DP
RHÖN-KLINIKUM Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Cannabis law and clinic atlas in the Bundesrat	Mar. 22	DP
Criticism of hospital reform: 'Redistribution from the bottom to the top'	Mar. 20	DP
Doctors strike at university hospitals	Mar. 11	DP
Doctors go on warning strike at 23 university hospitals	Mar. 11	DP
Agreement reached in collective bargaining for Giessen and Marburg University Hospital	Mar. 06	DP
Collective bargaining for Giessen and Marburg University Hospital to continue	Mar. 06	DP
Another warning strike at 23 university hospitals on March 11	Mar. 01	DP
Solution for transparency and financing at hospitals	Feb. 22	DP
Negotiations for Giessen and Marburg University Hospital continue	Feb. 18	DP
Further warning strikes and protests at Giessen and Marburg University Hospital	Feb. 14	DP
Rally and warning strike at Giessen and Marburg University Hospital	Feb. 12	DP
Fight against overcrowded emergency rooms - Lauterbach plans 'major reform'	Jan. 16	DP
Too few nursing staff: problem in hospitals set to increase according to study	Jan. 14	DP
Insurers urge progress on hospital reform	Jan. 05	DP
Hospitals demand clarity on financing of hospital reform	Nov. 23	DP
Federal government counts on further progress for hospital reform	Nov. 22	DP
Bavaria dampens hopes for swift agreement on hospital reform	Nov. 22	DP

Rhoen Klinikum AG is a Germany-based provider of health care services. The Company operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.

Sector

Healthcare Facilities & Services

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
RHÖN-KLINIKUM AG	+28.00%	923M
CVS HEALTH CORPORATION	-14.73%	85.42B
HCA HEALTHCARE, INC.	+16.05%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.73%	17.49B
FRESENIUS SE & CO. KGAA	-3.17%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-1.78%	15.28B
FRESENIUS MEDICAL CARE AG	-0.45%	12.22B
PURE HEALTH HOLDING	-31.23%	11.98B
EUROFINS SCIENTIFIC SE	-2.51%	11.71B

Other Healthcare Facilities & Services